FIGURE

Fig. 2

ID

ZDB-FIG-250218-59

Publication

Mo et al., 2024 - NAT10 functions as a pivotal regulator in gastric cancer metastasis and tumor immunity

Other Figures

All Figure Page

Back to All Figure Page

Fig. 2

Analyzing immune infiltration in two subgroups. (a) The Kaplan–Meier curves indicate a correlation between high NAT10 expression and unfavorable prognosis in STAD. (b) Mutation landscapes of the top 15 genes in populations with high and low NAT10 expression. (c) Variation in TMB expression observed between populations with high and low NAT10 expression. (d) GSEA (HALLMARK) between NAT10 high- and low-expression groups. (e) Variations in immunological and stromal scores between NAT10 high- and low-expression groups. (f) Differences between NAT10 high- and low-expression groups of the TCGA cohort in the infiltration of 22 immune cells. (g) Immune checkpoint variations across groups at NAT10 high- and low-expression. (h) Predicted outcomes of immune checkpoint blockade therapy response derived from the ImmuCellAI database. (i) Variations in TIDE scores between groups at NAT10 high- and low-expression. GSEA, gene set enrichment analysis; STAD, Stomach Adenocarcinoma.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J. Cell. Physiol.